STAT1 regulates MD-2 expression in monocytes of sepsis via miR-30a

Yanhong Wang1, Tiehua Li, Benquan Wu

  • 1Department of Medical Intensive Care Unit, The Third Affiliated Hospital of Sun Yat-Sen University, 600 Tianhe Road, Guangzhou, 510630, China.

Inflammation
|May 27, 2014
PubMed

Insights

MicroRNA-30a (miR-30a) inhibits Myeloid differentiation factor 2 (MD-2) expression in human monocytes by targeting STAT1. This discovery offers new insights into sepsis regulation and potential therapeutic targets.

Area of Science:

  • Immunology
  • Molecular Biology
  • Critical Care Medicine

Background:

  • Sepsis is a leading cause of death in critically ill patients.
  • Myeloid differentiation factor 2 (MD-2) is crucial in the Toll-like receptor 4 (TLR4) pathway but its regulation in sepsis is unclear.
  • Understanding MD-2 regulation is vital for developing effective sepsis treatments.

Purpose of the Study:

  • To elucidate the molecular mechanisms regulating MD-2 expression in sepsis.
  • To investigate the role of Interleukin-10 (IL-10) and Signal transducer and activator of transcription 1 (STAT1) in MD-2 regulation.
  • To identify microRNAs involved in the STAT1-MD-2 pathway.

Main Methods:

  • Real-time RT-PCR and ELISA were used to analyze cytokine expression in monocytes.
  • Western blotting was employed to detect STAT1 activation.
  • Bioinformatic prediction and experimental validation identified miR-30a as a regulator of STAT1.

Main Results:

  • Lipopolysaccharide (LPS) treatment significantly elevated IL-10 levels in monocytes.
  • IL-10 treatment activated STAT1, which enhanced MD-2 expression transcriptionally and posttranscriptionally.
  • miR-30a was confirmed as a direct target of STAT1, inhibiting IL-10-induced cytokine release by targeting the STAT1-MD-2 axis.

Conclusions:

  • This study reveals that miR-30a inhibits MD-2 expression by targeting STAT1 in human monocytes.
  • The miR-30a/STAT1/MD-2 pathway represents a novel regulatory mechanism in sepsis.
  • Targeting this pathway could offer new therapeutic strategies for sepsis management.

Related Concept Videos

Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.0K
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
16
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K